Skip to main content

Table 2 Restaging of patients on PET/CT and burden of disease (in terms of size and metabolic activity, i.e., SUVmax)

From: Impact of 18F FDG PET/CT on management of incidental gallbladder carcinoma

Patient no.

Time between surgery and PET/CT scan (in weeks)

PET/CT findings (positive/negative)

Local/residual disease/liver infiltration

Size (cm)

SUVmax

Regional lymph nodes

Number of regional lymph nodes (1–3/ ≥ 4)

Size of largest (cm)

SUVmax

Distant site of metastases

Location (largest)

Size

SUVmax

1

8

+

Peripancreatic, celiac

 ≥ 4

1.4 × 1.0

7.7

Abdominal, retroperitoneal, left supraclavicular lymph nodes and pulmonary nodules

Gastrohepatic lymph node

1.4 × 0.8

10.8

2

6

  

 

3

7

+

Infiltration into liver

2.7 × 3.1

12.1

Periportal

2

1.1 × 1.0

5.3

Right cervical level Vb, mediastinum & periportal lymph nodes, port site, peritoneal, mesenteric deposits

Port site

3.5 × 2.8

12.0

4

12

+

Infiltration into liver

3.1 × 2.0

6.1

5

8

+

Infiltration into liver

2.8 × 2.6

8.5

6

10

+

Infiltration into liver

3.2 × 2.1

9.3

 

7

7

 

8

10

 

9

10

+

Infiltration into liver

2.7 × 2.6

8.1

10

8

11

9

12

12

13

12

+

Infiltration into liver

2.6 × 2.5

11.5

Abdominal, mesenteric and retroperitonal lymph nodes, bilateral adrenal deposits

Portocaval lymph node & left adrenal

1.1 × 1.0 & 1.4 × 1.3

4.1 & 4.9

14

12

+

Infiltration into liver

4.7 × 5.2

11.3

Cystic, portal

3

1.3 × 1.1

4.2

Omental deposits

2.5 × 2.3

5.6

15

10

  

 

16

10

+

Infiltration into liver

3.1 × 2.7

10.2

Aortocaval lymph node

Aortocaval lymph node

1.1 × 1.0

10.2

17

8

+

Infiltration into liver

2.3 × 28

8.4